Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Change in Acquisitions & Divestments: 2023-2025

Historic Change in Acquisitions & Divestments for Collegium Pharmaceutical (COLL) over the last 2 years, with Sep 2025 value amounting to $14.6 million.

  • Collegium Pharmaceutical's Change in Acquisitions & Divestments fell 50.49% to $14.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $61.3 million, marking a year-over-year decrease of 33.81%. This contributed to the annual value of $92.6 million for FY2024, which is 320.92% up from last year.
  • As of Q3 2025, Collegium Pharmaceutical's Change in Acquisitions & Divestments stood at $14.6 million, which was up 5.84% from $13.8 million recorded in Q2 2025.
  • In the past 5 years, Collegium Pharmaceutical's Change in Acquisitions & Divestments ranged from a high of $29.4 million in Q3 2024 and a low of $13.8 million during Q2 2025.
  • Over the past 3 years, Collegium Pharmaceutical's median Change in Acquisitions & Divestments value was $16.5 million (recorded in 2023), while the average stood at $19.2 million.
  • Data for Collegium Pharmaceutical's Change in Acquisitions & Divestments shows a maximum YoY crashed of 50.49% (in 2025) over the last 5 years.
  • Over the past 3 years, Collegium Pharmaceutical's Change in Acquisitions & Divestments (Quarterly) stood at $16.0 million in 2023, then fell by 0.15% to $16.0 million in 2024, then plummeted by 50.49% to $14.6 million in 2025.
  • Its last three reported values are $14.6 million in Q3 2025, $13.8 million for Q2 2025, and $17.0 million during Q1 2025.